Pages • 3
Brainstrorm Cell Therpay Essay Preview: Brainstrorm Cell Therpay Report this essay BrainStorm Cell Therapeutics, Inc. OTC BB: BCLI Executive Summary October 2007 Contact information: Chaim Levinson Investor Relations Director [email protected] Mobile: 972-545-633683 BrainStorm’s Value Proposition BrainStorm is an early stage biotechnology company focused on developing innovative adult stem cell therapies for highly debilitating neurodegenerative disorders,.